Partnership for Safe Medicines Commends White House Forum on Fake Drugs

Partnership for Safe Medicines Board of Directors’ member Bryan A. Liang, MD, PhD, JD, released the following statement regarding today’s White House forum on the risks of counterfeit medicines.

“I am pleased that the White House continues to address the issue of counterfeit drugs and the serious health risk they pose to Americans – sick or well.

[...]

Partnership For Safe Medicines (PSM) India Launches 24-Hour Helpline

The Partnership for Safe Medicines (PSM) India, a group of nonprofit organizations and individuals dedicated to protecting consumers from spurious drugs, today announced the availability of a 24-hour helpline (1800-11-4424) to assist, educate and empower consumers across India.

[...]

FDA Commissioner Margaret Hamburg Joins with Public and Private Sector Leaders in Call to Address Global Counterfeit Drug Crisis

Washington, D.C. (October 8, 2010) – The U.S. Food and Drug Administration (FDA) is committed to keeping American drugs safe and needs new regulatory authority to do so, said Dr. Margaret Hamburg, Commissioner of the FDA, in prepared remarks at today’s inaugural Counterfeit Drug Interchange Conference hosted by the Partnership for Safe Medicines (PSM). The conference brought together more than a hundred cross-industry stakeholders to discuss ways to stem the rising tide of counterfeit and unsafe medicines.

“The FDA is firmly committed to doing all that we can to further strengthen our nation’s drug supply and ensure the quality and safety of all drugs and medical products on the U.S. market,” said Hamburg. “It is clear that FDA needs new regulatory tools that provide the authority we need to meet the challenges we face in today’s increasing globalized marketplace. And we look forward to working with Congress on legislation that will give FDA the ability to protect Americans from harmful drugs and medical products—and fulfill our fundamental public health mission.”

[...]

Partnership for Safe Medicines (PSM) Commends White House On Counterfeit Drug Provisions in U.S. Intellectual Property Enforcement Coordinator Plan

Washington, D.C. (June 22, 2010) – Scott LaGanga, executive director of the Partnership for Safe Medicines, released the following statement regarding today's rollout of a joint strategic plan by the U.S. Intellectual Property Enforcement Coordinator (IPEC) that includes provisions to address counterfeit prescription drugs: "The report released today is both a step forward and a…

[...]

Partnership for Safe Medicines (PSM) Joins with Irish Patients Association to Combat Counterfeit Medicine Threat

T.D Minister for Health Mary Harney Attends International Dialogue with Leading Industry, Health, Government Officials, Regulators, Law Enforcement and Patient Advocates DUBLIN (June 4, 2010) – Citing a growing, public and borderless health threat posed by the availability of primarily counterfeit prescription medicines around the globe, the Partnership for Safe Medicines (PSM) today joined with…

[...]